thednacompany.com
The DNA Company Wins “Functional Genomics Innovation of the Year”
The DNA Company has been honored with the Functional Genomics Innovation of the Year award at the 2025 BioTech Breakthrough Awards. This recognition celebrates our leadership in advancing personalized health through functional genomics — empowering people to unlock their biological potential and live longer, healthier lives.
Read Full AnnouncementTracy Wood Featured in MSN’s “Top 20 Women Leading Biohacking & Longevity”
This feature highlights Tracy’s groundbreaking leadership in precision wellness and her mission to make DNA-based, personalized health solutions accessible to everyone. Through her work at The DNA Company, Tracy continues to redefine how individuals understand their biology—empowering them to optimize energy, focus, and long-term health.
As a recognized voice in the wellness community, Tracy’s inclusion in MSN’s global spotlight reinforces our shared commitment to bridging science-backed genomics with compassionate care and real-world transformation.
Read Full Article
Tracy Wood, CPC, ELi-MP, HHA, CFGP
Chief Executive Officer, The DNA Company
Dr. Krista Kostroman Featured in Daily Mail
We’re excited to share that The DNA Company was prominently featured in a new piece from Daily Mail titled, Mystery of ancient DNA marker rewrites story of how humans first reached the Americas. This feature highlights the groundbreaking discovery of Haplogroup X, a genetic marker that challenges long-standing migration theories about how early humans reached the Americas.
Read Daily Mail Article
Dr. Krista Kostroman, ND, BCS, FGP
Chief Science Officer of The DNA Company
Dr. Krista Kostroman, ND, BCS, FGP
Chief Science Officer of The DNA Company
Dr. Krista Kostroman Featured in The Flow Space
Dr. Krista Kostroman, ND, BCS, FGP, Chief Science Officer at The DNA Company, was recently featured in The Flow Space in an article exploring how beauty standards are evolving for breast cancer survivors.
In her interview, Dr. Kostroman sheds light on the vital role of functional genomics in understanding the body’s healing capacity and redefining self-image after medical treatments. She emphasizes that the path to recovery isn’t just physical — it’s deeply personal and rooted in how women reconnect with their bodies after trauma.
Dr. Krista Kostroman Featured in SingleCare
We’re proud to share that Dr. Krista Kostroman, ND, BCS, FGP, Chief Science Officer at The DNA Company,
was recently featured in SingleCare’s article,
“Repatha Savings: How to Get the Best Price on This Cholesterol-Lowering Medication.”
In the piece, Dr. Kostroman provides expert insights into how genetics can influence the body’s response
to cholesterol medications like Repatha. She highlights the importance of personalized medicine in
optimizing treatment outcomes and reducing side effects — a step toward more informed, DNA-based healthcare.
Dr. Krista Kostroman, ND, BCS, FGP
Chief Science Officer of The DNA Company
Dr. Stephanie Nielsen Featured in Parade
We’re thrilled to share that Dr. Stephanie Nielsen, PharmD, CCN, CFGP—pharmacist and functional genomics practitioner at The DNA Company—was recently featured in Parade for her expert insights on nutrient absorption and wellness.
In this article, Dr. Nielsen explained how calcium and magnesium share absorption pathways—using a clever, real-world analogy comparing it to a ride-share system to help readers visualize how these minerals interact within the body.
Dr. Stephanie Nielsen, PharmD, CCN, CFGP
Functional Genomics Practitioner, The DNA Company
Dr. Stephanie Nielsen, PharmD, CCN, CFGP
Functional Genomics Practitioner, The DNA Company
Dr. Stephanie Nielsen Featured in TruMed
In her TruMed feature, Dr. Nielsen shared her expert advice on how vitamins and supplements can qualify for HSA reimbursement when prescribed for specific medical conditions.
She highlighted the importance of professional guidance and proper documentation to ensure accessibility and affordability in health and wellness—aligning with The DNA Company’s mission to make personalized healthcare easier to access for everyone.
